Babaran, Geraldine .
HRN: 27-10-43 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/12/2025
CEFUROXIME 500MG (TAB)
05/13/2025
05/19/2025
ORAL
500mg
2 Times A Day
S/P LTCS
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes